Julen Oyarzabal

PhD
Cima-Universidad de Navarra

Presentation(s):

• OC 76.4 - CM-352 reduces rivaroxaban-associated ICH by mechanisms dependent on MMP-10 and fibrinolysis inhibition

  Wednesday, July 13, 2022
  11:00 AM – 11:15 AM